On September 9, 2020 Onconova Therapeutics, Inc. (NASDAQ: ONTX) a biopharmaceutical company focused on discovering and developing novel products to treat cancer, reported that the Company plans to participate in several upcoming events (Press release, Onconova, SEP 9, 2020, View Source [SID1234564836]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Marcus Evans Healthcare Investment Webinar
Participation on panel titled "Exploring ESG Investment Opportunities in Healthcare amidst COVID-19" on Thursday, September 10 at 1:00 PM ET

H.C. Wainwright 22nd Annual Global Investment Conference
Company presentation on Monday, September 14 at 1:30 PM ET
Webcast information: View Source

2nd Annual RAS-Targeted Drug Development Conference
Company presentation titled "Rigosertib as a Unique Small Molecule RAS Antagonist: Scientific & Clinical Studies" on Wednesday, September 16 at 11:30 AM ET and panel discussion at 12:50 PM ET